Medicure reports earnings for the first quarter of 2024

Medicure (CVE:MPH) Q1 2024 Results

Key financial results

• Revenue: CAD 5.69 million (up 1.2% compared to Q1 2023).

• Net profit: PLN 51.0 thousand CAD (down 82% compared to Q1 2023).

• Profit margin: 0.9% (down from 5.2% in Q1 2023). The decline in margin resulted from higher costs.

All data shown in the chart above is for a 12-month (TTM) period.

Medicure shares increased by 3.0% compared to a week ago.

Risk assessment

We should say we discovered it 1 warning sign for Medicure what you should know before investing here.

Have an opinion on this article? Worried about content? contact with us directly. Alternatively, email the editorial team (at) simplywallst.com.

This article by Simply Wall St is of a general nature. We comment based on historical data and analyst forecasts, using only an unbiased methodology, and our articles are not intended to provide financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. Our goal is to provide long-term, focused analysis based on fundamental data. Please note that our analysis may not reflect the latest price-sensitive company announcements or qualitative content. Simply Wall St has no position in any of the stocks mentioned.